Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimen

Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimen

The aim of this study was to identify the first abnormalities of apolipoprotein B (apoB) metabolism in HIV-infected patients treated by antiretroviral therapy (ART) with protease inhibitors (PIs). The influence of ART on the metabolism of apoB in VLDL, IDL, and LDL was investigated in six patients r...

Full description

Bibliographic Details
Main Authors: Jean Michel Petit, Michel Duong, Emmanuel Florentin, Laurence Duvillard, Pascal Chavanet, Jean Marcel Brun, Henri Portier, Philippe Gambert, Bruno Vergès
Format: Article
Language:English
Published: Elsevier 2003-09-01
Series:Journal of Lipid Research
Subjects:
HIV protease inhibitor
nucleoside reverse transcriptase inhibitor
antiretroviral therapy
metabolism abnormalities
apolipoprotein B
dyslipidemia
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520337329

Internet

http://www.sciencedirect.com/science/article/pii/S0022227520337329

Similar Items